Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer.

Autor: Galsky, Matthew D., Mortazavi, Amir, Milowsky, Matthew I., George, Saby, Gupta, Sumati, Fleming, Mark T., Dang, Long H., Geynisman, Daniel M., Walling, Radhika, Alter, Robert S., Kassar, Mohamad, Wang, Jue, Gupta, Shilpa, Davis, Nancy, Picus, Joel, Philips, George, Quinn, David I., Haines III, G. Kenneth, Hahn, Noah M., Zhao, Qianqian
Zdroj: Journal of Clinical Oncology; 6/1/2020, Vol. 38 Issue 16, p1797-1806, 11p
Databáze: Supplemental Index